Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.370
0.00 (0.00%)
May 8, 2024, 1:01 PM EDT - Market open

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.

Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings logo
Country United States
Founded 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 70
CEO Scott G. Davis

Contact Details

Address:
101 Glacier Point, Suite A
San Rafael, California 94901
United States
Phone 510-984-1761
Website eksobionics.com

Stock Details

Ticker Symbol EKSO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001549084
CUSIP Number 282644301
ISIN Number US2826443010
SIC Code 3569

Key Executives

Name Position
Scott G. Davis Chief Executive Officer and Director
Jerome Wong Corporate Controller, Corporate Secretary and Chief Financial Officer
Jason C. Jones Chief Operating Officer
Rachael Anderson Global Director of Marketing and Strategic Growth
Anthony Pratt Vice President of Sales
Ann Cookson Human Resources Director
Foon Lim Chwee President of APAC
Stephan Aderhold Senior Vice President and GM of EMEA

Latest SEC Filings

Date Type Title
Apr 29, 2024 10-Q Quarterly Report
Apr 29, 2024 8-K Current Report
Apr 26, 2024 ARS Filing
Apr 26, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2024 DEF 14A Other definitive proxy statements
Mar 18, 2024 S-8 Securities to be offered to employees in employee benefit plans
Mar 18, 2024 11-K Annual report of employee stock purchase, savings and similar plans
Mar 4, 2024 10-K Annual Report
Mar 4, 2024 8-K Current Report
Jan 16, 2024 8-K Current Report